# EMGALITY

NDC: 0002-3115
Generic name: galcanezumab-gnlm
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190604

FDA application: BLA761063

## Active ingredients

- GALCANEZUMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-3115"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-3115
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33a147be-233a-40e8-a55e-e40936e28db0